Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-05

Clinical Trial Update: A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FCD105 foam to minocycline, adapalene, and vehicle foams in acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene 0.3% foam (adapalene)
  • FCD105 foam (FCD105)
  • Minocycline 3% foam (minocycline)
  • Vehicle Foam

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED